Spark Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Spark Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-51,500	Closed	-$216K	–	373
2020 Q1	$216K	Sell	51,500 -53,900	-51%	-$340K	0.11%	223
2019 Q4	$414K	Sell	105,400 -38,200	-27%	-$226K	0.05%	367
2019 Q3	$1.26M	Sell	143,600 -86,764	-38%	-$820K	0.16%	158
2019 Q2	$2.13M	Sell	230,364 -154,553	-40%	-$1.16M	0.15%	191
2019 Q1	$2.48M	Buy	384,917 +261,922	+213%	+$1.71M	0.11%	218
2018 Q4	$1.16M	Buy	+122,995	New	+$1.85M	0.08%	294
2014 Q2	–	Sell	-27,800	Closed	-$300K	–	885
2014 Q1	$300K	Buy	+27,800	New	+$273K	0.05%	451

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Spark Investment Management's LJPC Position: Q2 2020 in Review

Spark Investment Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 51,500 shares — an estimated $216K sold.

Spark Investment Management first reported a position in LJPC in Q1 2014 and held it in 7 quarters. The position peaked at $2.48M in Q1 2019. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

Spark Investment Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
Spark Investment Management sold 51,500 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $216K.
Spark Investment Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 7 quarters.
Spark Investment Management's La Jolla Pharmaceutical Company position peaked at $2.48M in Q1 2019.
76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.